Cost utility analysis of adult patients with severe aplastic anemia: a single-center study

Cost utility analysis of adult patients with severe aplastic anemia: a single-center study

Objective There is a need for real-world studies in China to help address evidence gaps supporting precise clinical decision-making with respect to the ideal treatment options for patients with severe aplastic anemia (SAA). Accordingly, we objectively evaluated the efficacy of cyclosporine A (CsA) +...

Full description

Saved in:
Bibliographic Details
Main Authors: Lin Chen, Liwei Fang, Zhexiang Kuang, Jing Xu, Chuan Wang
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Hematology
Subjects:
Severe aplastic anemia (SAA)
cyclosporine A (CsA)
antilymphocyte globulin (ALG)
cost-utility analysis (CUA)
quality-of-life adjusted years (QALY)
incremental cost-utility ratio (ICUR)
Online Access:https://www.tandfonline.com/doi/10.1080/16078454.2025.2492925
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/16078454.2025.2492925

Similar Items